Skip to main content
. 2024 Jun 15;7:157. doi: 10.1038/s41746-024-01152-2

Fig. 3. Direction of findings and risk of bias assessment for included studies.

Fig. 3

The assessment is reported by outcome categories and clinical areas including healthcare utilization outcomes (A), clinical outcomes (B), and process outcomes (C). We assessed the risk of bias using the Cochrane Risk of Bias Tool, Version 2, for randomized controlled trials. The tool categorized the risk of bias into low, some concerns, and high. All three randomized clinical trials included in this review were assessed to have a high risk of bias. COVID-19 coronavirus disease 2019, ED emergency department, RCT randomized clinical trial.